Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Annals of Hematology|June 28, 2018
Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignanciesManar M I Khalil, Hans A Messner, Jeffrey H Lipton, et al.
European Journal of Haematology|December 15, 2017
Outcome following second allogeneic hematopoietic cell transplantation: A single-center experienceHassan A Aljasem, Hans A Messner, Jeffrey H Lipton, et al.
Annals of Hematology|May 9, 2020
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantationIvan Pasic, Jeffrey H Lipton, Dennis D Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2017
Incidence and Risk Factors for Nontuberculous Mycobacterial Infection after Allogeneic Hematopoietic Cell TransplantationJennifer Beswick, Elizabeth Shin, Fotios V Michelis, et al.
European Journal of Haematology|August 8, 2019
Epstein-Barr virus associated post-transplant lymphoproliferative disorder mimicking acute graft versus host diseaseShruti Prem, Zeyad Al-Shaibani, Fotios V Michelis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 19, 2013
Benefit of allogeneic transplantation in patients age ≥ 60 years with acute myeloid leukemia is limited to those in first complete remission at time of transplantFotios V Michelis, Hans A Messner, Eshetu G Atenafu, et al.
European Journal of Haematology|April 15, 2014
Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell graftsFotios V Michelis, Hans A Messner, David Loach, et al.
European Journal of Haematology|November 19, 2019
Allogeneic stem cell transplant in myelodysplastic syndrome-factors impacting survivalShruti Prem, Eshetu G Atenafu, Wilson Lam, et al.
European Journal of Haematology|February 2, 2019
Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AMLIvan Pasic, Waleed Da'na, Wilson Lam, et al.
European Journal of Haematology|May 31, 2017
Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1Christianne Bourlon, Jeffrey H Lipton, Uday Deotare, et al.
Pageof 13